We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLB icon
301
Dolby
DLB
$5.79B
$450K 0.04%
6,282
+3,312
+112% +$251K
FTV icon
302
Fortive
FTV
$18.6B
$450K 0.04%
+10,973
New +$485K
DEI icon
303
Douglas Emmett
DEI
$1.96B
$446K 0.04%
+19,934
New +$556K
DINO icon
304
HF Sinclair
DINO
$14.5B
$441K 0.04%
+9,759
New +$437K
SBUX icon
305
Starbucks
SBUX
$120B
$439K 0.04%
5,745
-5,095
-47% -$391K
PRLD icon
306
Prelude Therapeutics
PRLD
$390M
$438K 0.04%
+83,867
New +$427K
AIG icon
307
American International
AIG
$41.3B
$434K 0.04%
8,489
– –
NKTR icon
308
Nektar Therapeutics
NKTR
$2.58B
$433K 0.04%
+7,594
New +$479K
CBRE icon
309
CBRE Group
CBRE
$42.9B
$432K 0.04%
+5,867
New +$472K
M icon
310
Macy's
M
$6.68B
$432K 0.04%
23,605
+14,605
+162% +$330K
HALO icon
311
Halozyme
HALO
$12.2B
$430K 0.04%
+9,782
New +$423K
PARA
312
DELISTED
Paramount Global Class B
PARA
$430K 0.04%
+17,404
New +$530K
AD
313
Array Digital Infrastructure
AD
$3.05B
$426K 0.04%
+14,707
New +$441K
B
314
DELISTED
Barnes Group Inc.
B
$423K 0.04%
+13,581
New +$473K
KDP icon
315
Keurig Dr Pepper
KDP
$40.8B
$422K 0.04%
+11,914
New +$432K
A icon
316
Agilent Technologies
A
$41.2B
$416K 0.04%
3,505
-1,113
-24% -$137K
ZUMZ icon
317
Zumiez
ZUMZ
$339M
$412K 0.04%
+15,855
New +$534K
UNM icon
318
Unum
UNM
$14.3B
$411K 0.04%
12,076
-10,524
-47% -$356K
KRC icon
319
Kilroy Realty
KRC
$4.42B
$410K 0.04%
+7,838
New +$497K
MCO icon
320
Moody's
MCO
$82.7B
$406K 0.04%
1,492
+490
+49% +$147K
CWEN.A
321
DELISTED
Clearway Energy Class A
CWEN.A
$402K 0.04%
+12,564
New +$391K
HUYA
322
Huya Inc
HUYA
$558M
$399K 0.04%
102,921
-43,318
-30% -$181K
TRN icon
323
Trinity Industries
TRN
$2.38B
$398K 0.04%
+16,452
New +$444K
CIEN icon
324
Ciena
CIEN
$58.4B
$396K 0.04%
+8,665
New +$449K
OPI
325
DELISTED
Office Properties Income Trust
OPI
$395K 0.04%
19,792
– –
11 12
13
14 15

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.